Ontrak, Inc. (OTRK)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ontrak, Inc. (OTRK) trades at $0.33 with AI Score 53/100 (Grade B). Ontrak, Inc. is a healthcare technology company specializing in AI-driven telehealth solutions for chronic disease management. Market cap: $2.34M, Sector: Healthcare.
Price live · AI analysis from May 10, 2026Analyst Coverage for OTRK: OTRK does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates OTRK against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
OTRK: 3/7 perspectives are bullish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Ontrak, Inc. (OTRK) Healthcare & Pipeline Overview
Ontrak, Inc. leverages artificial intelligence and telehealth to deliver innovative healthcare solutions for chronic disease management, addressing behavioral health needs and enhancing patient engagement through technology-driven care pathways.
What Is the Investment Thesis for OTRK?
Ontrak, Inc. presents a compelling investment thesis driven by its innovative approach to chronic disease management through AI and telehealth solutions. The company's technology-enabled platform is designed to predict and improve patient outcomes, which is increasingly relevant in today's healthcare landscape. With a focus on behavioral health and chronic conditions, Ontrak targets a significant market, estimated to reach $250 billion by 2027. Key growth catalysts include expanding partnerships with health plans and third-party payors, which can enhance revenue streams and market penetration. Additionally, the company's gross margin of 51.6% indicates a strong operational efficiency compared to industry peers. However, potential risks include ongoing financial losses, as evidenced by a profit margin of -233.4%, which could impact future funding and operational stability. Overall, Ontrak's unique positioning and technology-driven solutions provide a solid foundation for future growth.
Based on FMP financials and quantitative analysis
OTRK Key Highlights
- Gross margin of 51.6%, indicating strong operational efficiency.
- Market cap currently at $0.00B, reflecting the company's financial challenges.
- Profit margin of -233.4%, highlighting ongoing financial losses.
- Beta of 1.53, suggesting higher volatility compared to the market.
- No dividend yield, indicating a focus on reinvestment rather than returning capital to shareholders.
Who Are OTRK's Competitors?
OTRK is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AMWL American Well Corporation (AMWL) | $9.28 | +0.27% | $154.97M | — |
| CLOV Clover Health Investments, Corp. | $5.04 | -4.18% | $2.61B | 36 |
| HCA HCA Healthcare, Inc. | $415.66 | +1.26% | $92.21B | 86 |
| CARL CARLSMED, INC. | $11.90 | +4.94% | $323.50M | 70 |
| HNGE Hinge Health, Inc. | $89.42 | +6.39% | $6.92B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.95 | +0.00% | $39.09M | 67 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.10M | 67 |
| RCM R1 RCM Inc. | $14.31 | +0.00% | $6.04B | 54 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are OTRK's Key Strengths?
- Innovative AI-powered platform for chronic disease management.
- Strong gross margin indicating operational efficiency.
- Holistic approach addressing both medical and psychosocial needs.
- Established brand recognition after rebranding from Catasys.
What Are OTRK's Weaknesses?
- Negative profit margin indicating ongoing financial challenges.
- Limited market cap reflecting investor concerns.
- Dependence on partnerships for revenue generation.
- High beta indicating potential volatility in stock performance.
What Could Drive OTRK Stock Higher?
- Expansion of partnerships with additional health plans to enhance service delivery.
- Development of new features for the OnTrak program to improve patient engagement.
- Anticipated regulatory changes that may support telehealth reimbursement.
- Continuous improvement in technology to enhance patient outcomes.
What Are the Key Risks for OTRK?
- Financial-distress signal — its Altman Z-Score of -46.07 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Ongoing financial losses could hinder operational stability and growth.
- High competition in the healthcare technology sector may impact market share.
- Regulatory changes could affect the reimbursement landscape for telehealth services.
- Economic factors may influence healthcare spending and demand for services.
What Are the Growth Opportunities for OTRK?
- Expansion into New Markets: Ontrak, Inc. is poised to expand its services into new geographic markets, particularly in regions with high rates of chronic disease. The U.S. chronic disease management market is projected to reach $250 billion by 2027, providing significant growth potential for Ontrak as it seeks to partner with additional health plans and payors.
- Technological Advancements: The company continues to enhance its AI-driven platform, which could lead to improved patient outcomes and greater engagement. As technology evolves, Ontrak's ability to integrate new tools and methodologies will strengthen its market position and attract more clients.
- Partnership Development: Ontrak has opportunities to forge strategic partnerships with healthcare providers and payors, which can enhance its service offerings and expand its client base. Collaborations with major health plans could drive revenue growth and increase the adoption of its OnTrak program.
- Increased Focus on Behavioral Health: With a growing recognition of the importance of mental health in chronic disease management, Ontrak is well-positioned to capitalize on this trend. The company’s integrated approach to addressing behavioral health alongside chronic conditions aligns with industry shifts towards holistic patient care.
- Regulatory Support for Telehealth: As telehealth continues to gain acceptance and support from regulatory bodies, Ontrak stands to benefit from increased demand for its services. The expansion of telehealth reimbursement policies will likely enhance the company’s growth prospects and market reach.
What Opportunities Does OTRK Have?
- Expansion into new geographic markets with high chronic disease rates.
- Technological advancements enhancing service offerings.
- Increased focus on behavioral health in chronic disease management.
- Regulatory support for telehealth services driving demand.
What Threats Does OTRK Face?
- Intense competition in the healthcare technology space.
- Potential regulatory changes impacting telehealth reimbursement.
- Economic downturns affecting healthcare spending.
- Rapid technological changes requiring continuous adaptation.
What Are OTRK's Competitive Advantages?
- Unique integration of AI technology with telehealth services.
- Strong focus on behavioral health, differentiating from traditional providers.
- Established partnerships with health plans enhance market credibility.
- Proven track record of improving patient outcomes through personalized care.
What Does OTRK Do?
Ontrak, Inc., founded in 2003 and originally known as Catasys, Inc., is a Miami-based healthcare technology company that specializes in artificial intelligence-powered, telehealth-enabled solutions. The company focuses on providing in-person services to health plans and third-party payors across the United States. Ontrak's flagship program, the OnTrak program, is designed to identify individuals with chronic diseases who would benefit from behavior change and personalized care pathways. By integrating evidence-based psychosocial and medical interventions, Ontrak addresses various chronic conditions such as diabetes, hypertension, and chronic obstructive pulmonary disease. The company employs a combination of telehealth services and in-person care coaching, supported by community care coordinators who help patients navigate their healthcare journeys. This holistic approach not only improves health outcomes but also addresses social and environmental determinants of health, making Ontrak a unique player in the healthcare landscape. The company rebranded to Ontrak, Inc. in July 2020 to better reflect its mission and services. Today, Ontrak continues to evolve its technology platform, aiming to enhance patient engagement and drive better health outcomes through innovative healthcare solutions.
What Products and Services Does OTRK Offer?
- Provide AI-driven healthcare solutions for chronic disease management.
- Offer telehealth-enabled services to improve patient engagement.
- Integrate psychosocial and medical interventions to address behavioral health.
- Deliver personalized care pathways for individuals with chronic conditions.
- Utilize community care coordinators to support patients in navigating healthcare.
- Focus on improving health outcomes through evidence-based practices.
How Does OTRK Make Money?
- Generate revenue through partnerships with health plans and third-party payors.
- Leverage technology to deliver scalable healthcare solutions.
- Provide in-person and telehealth services to enhance patient care.
- Utilize data analytics to improve patient outcomes and operational efficiency.
What Industry Does OTRK Operate In?
The healthcare information services industry is rapidly evolving, driven by the increasing demand for telehealth solutions and AI technologies. The market is projected to grow significantly, with a CAGR of approximately 15% over the next five years, fueled by advancements in technology and a shift towards value-based care. Ontrak, Inc. is well-positioned within this landscape, offering innovative solutions that address the growing need for chronic disease management and behavioral health support. The competitive landscape includes established players and emerging startups, all vying for market share in a space that is becoming increasingly crowded. Ontrak's unique focus on integrating psychosocial interventions with medical care sets it apart from traditional healthcare providers.
Who Are OTRK's Key Customers?
- Health plans seeking to enhance chronic disease management.
- Third-party payors looking for innovative healthcare solutions.
- Patients with chronic conditions requiring behavioral health support.
- Healthcare providers interested in integrating telehealth services.
Company Profile
Ontrak, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Miami, US. The company is led by CEO Brandon H. LaVerne CPA. OTRK has traded publicly since 2003.
F-Score 1/9Financial Health
Ontrak, Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -46.07 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on assets is -66.0%, showing how much profit it generates from its asset base. A current ratio of 0.72 means current liabilities exceed short-term assets, a liquidity point worth watching.
OTRK Valuation & Market Position
With a $2.34M market cap, Ontrak, Inc. sits in the micro-cap segment of the market. Relative to its peer group, OTRK's quantitative score of 53/100 is below the peer average of 65/100.
FY2026 estForward Outlook
Wall Street analysts project Ontrak, Inc. revenue of about $22.1M for fiscal 2026, with EPS near $-2.32.
OTRK Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Innovative AI-powered platform for chronic disease management.
- Strong gross margin indicating operational efficiency.
- Holistic approach addressing both medical and psychosocial needs.
- Established brand recognition after rebranding from Catasys.
Bear Case
- Negative profit margin indicating ongoing financial challenges.
- Limited market cap reflecting investor concerns.
- Dependence on partnerships for revenue generation.
- High beta indicating potential volatility in stock performance.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
OTRK Latest News
No recent news available for OTRK.
OTRK Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for OTRK.
Price Targets
Wall Street price target analysis for OTRK.
OTRK MoonshotScore
What does this score mean?
The MoonshotScore rates OTRK's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Brandon H. LaVerne CPA
CEO
Brandon H. LaVerne is a certified public accountant with extensive experience in healthcare management and finance. He has held various leadership roles in healthcare organizations, focusing on operational efficiency and financial strategy. LaVerne has a strong educational background, holding a degree in accounting and finance, which equips him with the skills necessary to lead a healthcare technology company.
Track Record: Under LaVerne's leadership, Ontrak has rebranded and refocused its mission, enhancing its technology platform and expanding its service offerings. He has been instrumental in forging strategic partnerships that have improved the company's market position and financial outlook.
Common Questions About OTRK (Healthcare)
What does Ontrak, Inc. do?
Ontrak, Inc. specializes in providing AI-driven healthcare solutions aimed at improving chronic disease management. The company offers a telehealth-enabled platform that integrates psychosocial and medical interventions, helping patients navigate their healthcare journeys and achieve better health outcomes.
What do analysts say about OTRK stock?
Analysts have mixed views on OTRK stock, reflecting concerns about the company's financial performance and market position. Key valuation metrics indicate that while the company has a strong gross margin, its negative profit margin raises questions about sustainability. Growth considerations include the potential for expanding partnerships and enhancing service offerings.
What are the main risks for OTRK?
The primary risks for Ontrak, Inc. include ongoing financial losses, which could impact operational stability and growth prospects. Additionally, high competition in the healthcare technology sector poses a threat to market share, while potential regulatory changes may affect telehealth reimbursement. Economic factors could also influence healthcare spending and demand for Ontrak's services.
What are the key factors to evaluate for OTRK?
Ontrak, Inc. (OTRK) holds an AI score of 53/100 (moderate). Not financial advice.
How frequently does OTRK data refresh on this page?
OTRK prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven OTRK's recent stock price performance?
Ontrak, Inc. (OTRK) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative AI-powered platform for chronic disease management. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider OTRK overvalued or undervalued right now?
Valuing Ontrak, Inc. (OTRK) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying OTRK?
Before investing in Ontrak, Inc. (OTRK), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Data is based on the latest available financial and operational metrics. Future performance may vary based on market conditions and company developments.